Akita Hisanao, Ogata Masanori, Jitsuki Susumu, Ogura Taichi, Oh-Nishi Arata, Hoka Sumio, Saji Makoto
Department of Physiology, School of Allied Health Sciences, Kitasato University, Sagamihara 228-8555, Japan.
Brain Res. 2006 Jun 20;1095(1):178-89. doi: 10.1016/j.brainres.2006.04.039. Epub 2006 May 26.
To produce an animal model of a dopa-responsive motor disorder with depletion of dopamine (DA) release in the striatum by dysfunction of the transmitter release machinery of the nigrostriatal DA system, we performed an intra-nigral injection of an HVJ-liposome gene transfer vector containing antisense oligodeoxynucleotides (ODNs) against synaptotagmin I (SytI), a key regulator of Ca(2+)-dependent exocytosis and endocytosis in adult rats. A unilateral intra-nigral injection of HVJ-liposome vectors containing antisense ODNs against SytI (syt-AS) caused a moderate disruption of methamphetamine-induced release of DA in the treated side of the striatum, while the syt-AS treatment did not affect physiological release of DA in the treated striatum. A bilateral intra-nigral injection of HVJ-liposome vectors containing syt-AS induced an impairment of the striatal DA-mediated acquisition of skilled behavior in a rotarod task without any deficits in general motor functions, such as spontaneous locomotor activity, motor adjusting steps, equilibrium function, or muscle strength. These findings suggest that an intra-nigral treatment with HVJ-liposome vectors containing syt-AS may cause a long-lasting nigral knockdown of SytI which, in turn, leads to a moderate dysfunction of the DA release machinery in the terminals of the nigrostriatal DA system and a subsequent mild depletion of DA release in the striatum.
为了通过黑质纹状体多巴胺(DA)系统递质释放机制功能障碍,建立一种纹状体中DA释放减少的多巴反应性运动障碍动物模型,我们对成年大鼠进行了黑质内注射含有针对突触结合蛋白I(SytI)的反义寡脱氧核苷酸(ODNs)的HVJ - 脂质体基因转移载体。单侧黑质内注射含有针对SytI的反义ODNs(syt - AS)的HVJ - 脂质体载体,导致纹状体治疗侧甲基苯丙胺诱导的DA释放出现中度破坏,而syt - AS治疗不影响治疗纹状体中DA的生理释放。双侧黑质内注射含有syt - AS的HVJ - 脂质体载体,在转棒试验中诱导纹状体DA介导的熟练行为获得受损,而在一般运动功能方面没有任何缺陷,如自发运动活动、运动调整步骤、平衡功能或肌肉力量。这些发现表明,用含有syt - AS的HVJ - 脂质体载体进行黑质内治疗可能导致SytI在黑质中持久敲低,进而导致黑质纹状体DA系统终末的DA释放机制出现中度功能障碍,随后纹状体中DA释放轻度减少。